CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $1.4B, above the global median of $1.15B
- FinancialsAltman Z-Score 6.22: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.11%Above 5Y avg (1.11%)
Annual Rate
CNY 0.33Paid annual
Payout Ratio
67.1%Moderate
Payback Period
89.5 yr
Last Ex-Dividend
Jun 18, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
9.38BCNY1.40B · vs all stocks (USD)
Trailing P/E
42.91xvs Medical Devices peers
Revenue (TTM)
2.29BCNY340.81M · vs all stocks (USD)
Profit Margin
9.60%vs Medical Devices peers
Beta
0.5250xvs all stocks
52-Week Change
-15.82%vs all stocks
Market Capitalization
9.38BCNY1.40B · vs all stocks (USD)
Enterprise Value
7.61BCNY1.13B · vs all stocks (USD)
Trailing P/E
42.91xvs Medical Devices peers
Forward P/E
15.73xvs Medical Devices peers
Price to Sales (TTM)
4.15xvs Medical Devices peers
Price to Book (MRQ)
2.10xvs Medical Devices peers
Enterprise to Revenue
3.32xvs Medical Devices peers
Enterprise to EBITDA
28.90xvs Medical Devices peers
Gross Margin
47.55%vs Medical Devices peers
Profit Margin
9.60%vs Medical Devices peers
Operating Margin
11.56%vs Medical Devices peers
Return on Assets (TTM)
1.69%vs Medical Devices peers
Return on Equity (TTM)
4.65%vs Medical Devices peers
Revenue (TTM)
2.29BCNY340.81M · vs all stocks (USD)
Revenue per Share (TTM)
7.30CNYUpdated Aug 21, 2026Quarterly Revenue Growth
-5.40%vs Medical Devices peers
Gross Profit (TTM)
1.06BCNY157.42M · vs all stocks (USD)
EBITDA (TTM)
323.17MCNY48.06M · vs all stocks (USD)
Net Income (TTM)
219.93MCNY32.71M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-27.90%vs Medical Devices peers
Operating Cash Flow (TTM)
242.35MCNY36.04M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
93.24MCNY13.87M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.3300CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
1.11%vs all stocks
5-Year Average Dividend Yield
1.11%vs all stocks
Payout Ratio
67.14%vs Medical Devices peers
Minority Interest (Equity)
247.50MCNYFY2025 · Dec 31, 2025Revenue
2.33BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.24BCNYFY2025 · Dec 31, 2025Gross Profit
1.09BCNYFY2025 · Dec 31, 2025Operating Income
234.32MCNY34.85M · vs all stocks (USD)
Pre-tax Income
264.76MCNYFY2025 · Dec 31, 2025Income Tax Expense
9.63MCNYFY2025 · Dec 31, 2025Net Income
255.13MCNYFY2025 · Dec 31, 2025EBIT
268.67MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
415.38MCNYFY2025 · Dec 31, 2025Research & Development
323.25MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
209.45MCNYFY2025 · Dec 31, 2025Other Operating Expenses
22.65MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
35.37MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
3.91MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.8000CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.8000CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
313.41MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
313.41MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
255.13MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-4.40MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
113.41MCNYFY2025 · Dec 31, 2025Free Cash Flow
-5.39MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
553.81MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
255.13MCNYFY2025 · Dec 31, 2025Other Non-cash Items
-22.50MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-68.68MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-50.54MCNYFY2025 · Dec 31, 2025Capital Expenditures
-118.80MCNYFY2025 · Dec 31, 2025Net Acquisitions
-56.65MCNYFY2025 · Dec 31, 2025Purchase of Investments
-3.79BCNYFY2025 · Dec 31, 2025Sale of Investments
3.98BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
16.75MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
20.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-10.01MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-147.36MCNYFY2025 · Dec 31, 2025Other Financing Charges
-128.43MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-265.80MCNYFY2025 · Dec 31, 2025Shares Outstanding
316.49MSharesUpdated Aug 21, 2026Float Shares
148.05MSharesUpdated Aug 21, 2026% Held by Insiders
41.21%vs all stocks
% Held by Institutions
24.24%vs all stocks
Total Cash (MRQ)
1.48BCNY219.92M · vs all stocks (USD)
Total Cash per Share (MRQ)
4.74CNYUpdated Aug 21, 2026Total Debt (MRQ)
14.64MCNY2.18M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0031xvs Medical Devices peers
Current Ratio (MRQ)
2.57xvs Medical Devices peers
Book Value per Share (MRQ)
14.29CNYUpdated Aug 21, 2026Total Assets
5.79BCNY861.26M · vs all stocks (USD)
Total Current Assets
2.66BCNYFY2025 · Dec 31, 2025Total Liabilities
1.17BCNYFY2025 · Dec 31, 2025Total Non-current Assets
3.13BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
82.83MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.09BCNYFY2025 · Dec 31, 2025Cash
835.65MCNYFY2025 · Dec 31, 2025Cash Equivalents
8.18MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
843.83MCNYFY2025 · Dec 31, 2025Other Short-term Investments
447.59MCNYFY2025 · Dec 31, 2025Accounts Receivable
404.42MCNYFY2025 · Dec 31, 2025Inventory
345.47MCNYFY2025 · Dec 31, 2025Accounts Payable
429.38MCNYFY2025 · Dec 31, 2025Short-term Debt
90.60MCNYFY2025 · Dec 31, 2025Other Current Liabilities
16.40MCNYFY2025 · Dec 31, 2025Long-term Debt
4.54MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
6.31MCNYFY2025 · Dec 31, 2025Common Stock (Book)
317.95MCNYFY2025 · Dec 31, 2025Retained Earnings
2.16BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
4.62BCNY687.52M · vs all stocks (USD)
Treasury Stock
248.68MCNYFY2025 · Dec 31, 202552-Week Low
24.40CNYUpdated Aug 21, 202652-Week High
38.80CNYUpdated Aug 21, 202652-Week Change
-15.82%vs all stocks
Beta
0.5250xvs all stocks
50-Day MA
27.50CNYUpdated Aug 21, 2026200-Day MA
31.27CNYUpdated Aug 21, 2026Avg 10-Day Volume
3.92MSharesUpdated Aug 21, 2026Avg 30-Day Volume
3.82MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.7000CNYUpdated Aug 21, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
How does this company use capital?
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 6.22: safe zoneNotable
Altman Z-Score: 6.22
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $1.4B, above the global median of $1.15BNotable
Market cap (USD): 1,395,496,891.023Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Absci Corporation
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Jiangxi Fushine Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shanghai MicroPort EP MedTech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Chongqing Genrix Biopharma Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Chongqing Taiji Industry Group Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Aurora Optoelectronics Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlow
KalVista Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
HBM Holdings Limited
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
GenFleet Therapeutics (Shanghai) Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Phibro Animal Health Corporation
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Central China Land Media Co., Ltd.
3 interpretationsHigh Retained Earnings With Profitability And EquityMinimal Tax and Interest DragMulti-Year Debt Decrease With Cash Near Total Debt And Equity
China Shenhua Energy Company Limited
2 interpretationsHigh Retained Earnings With Profitability And EquityMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Great Eastern Shipping Company Ltd.
3 interpretationsHigh Retained Earnings With Profitability And EquityMinimal Tax and Interest DragMulti-Year Debt Decrease With Cash Near Total Debt And Equity